Home › NDC Lookup › Ingredients › Ocrelizumab And Hyaluronidase
📦 NDC / package directory — not a drug information page

Ocrelizumab And Hyaluronidase NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Ocrelizumab And Hyaluronidase products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

2
Package NDCs
2
Products
2
Active listings
0
Discontinued
1
Labelers
2
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
OCRELIZUMAB 23000 U/23mL; HYALURON... 1
OCRELIZUMAB 920 mg/23mL; HYALURONI... 1
By dosage form
INJECTION, SOLUTION 2
Top labelers
Genentech, Inc. 2

Browse records — 2 products

Drug / product Billing NDC NADAC / unit Status
Ocrevus Zunovo ocrelizumab and hyaluronidase 920 mg/23mL; 23000 U/23mL INJECTION, SOLUTION Genentech, · NDC 50242-0554-01 · J2351 · 1 VIAL, SINGLE-USE in 1 CARTON (50242-554-01) / 23 mL in 1 VIAL, SINGLE-USE 50242-0554-01 — On market View →
Ocrevus Zunovo ocrelizumab and hyaluronidase 920 mg/23mL; 23000 U/23mL INJECTION, SOLUTION Genentech, · NDC 50242-0554-01 · J2351 · 1 VIAL, SINGLE-USE in 1 CARTON (50242-554-01) / 23 mL in 1 VIAL, SINGLE-USE 50242-0554-01 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.